Analyst Coverage Initiated/Resumed |
Coverage Initiated
No. | Symbol | Company | Analyst Recommendation / Rating Change | Target Price | Date | Chart |
---|---|---|---|---|---|---|
1 | AGL | Agilon Health | Rating: Neutral | $-- | 06-24-2022 | View Chart |
2 | AMRS | Amyris | Rating: Neutral | $-- | 06-24-2022 | View Chart |
3 | BLCO | Bausch + Lomb | Rating: Outperform | $21 | 06-24-2022 | View Chart |
4 | BTMD | biote Corp. | Rating: Outperform | $11 | 06-24-2022 | View Chart |
5 | CAL | Caleres | Rating: Buy | $35 | 06-24-2022 | View Chart |
6 | CANO | Cano Health | Rating: Outperform | $8 | 06-24-2022 | View Chart |
7 | CORZ | Core Scientific | Rating: Outperform | $3.10 | 06-24-2022 | View Chart |
8 | CTMX | CytomX Therapeutics | Rating: Outperform | $9 | 06-24-2022 | View Chart |
9 | EXEL | Exelixis | Rating: Outperform | $28 | 06-24-2022 | View Chart |
10 | GMAB | Genmab | Rating: Market Perform | $34.73 | 06-24-2022 | View Chart |
11 | IRM | Iron Mountain | Rating: Overweight | $58 | 06-24-2022 | View Chart |
12 | MARA | Marathon Digital Holdings | Rating: Market Perform | $7 | 06-24-2022 | View Chart |
13 | NUVL | Nuvalent | Rating: Outperform | $28 | 06-24-2022 | View Chart |
14 | SBIG | Seibels Bruce Group, The | Rating: Buy | $4.50 | 06-24-2022 | View Chart |
15 | SGEN | Seagen | Rating: Market Perform | $169 | 06-24-2022 | View Chart |
16 | YMAB | Y-mAbs Therapeutics | Rating: Outperform | $27 | 06-24-2022 | View Chart |
Coverage Resumed
No. | Symbol | Company | Analyst Recommendation / Rating Change | Target Price | Date | Chart |
---|---|---|---|---|---|---|
1 | EDR | Endeavor Group | Rating: Outperform | $40 | 06-24-2022 | View Chart |
2 | SHOP | Shopify | Rating: Equal-Weight | $450 | 06-24-2022 | View Chart |
Reiterated/Price Target Changed
No. | Symbol | Company | Analyst Recommendation / Rating Change | Target Price | Date | Chart |
---|---|---|---|---|---|---|
1 | FDX | FedEx | Rating: Buy | $300>>312 | 06-24-2022 | View Chart |
2 | TSLA | Tesla | Rating: Outperform | $1125>>1000 | 06-24-2022 | View Chart |
Analyst Coverage Initiated/Resumed Stock Archives
Click on the date to view signals archives
Analyst Rating Change Signals
"Self-declared" experts have spoken, not only they upgrade and downgrade stocks, they're also issue equity ratings changes direct from brokerage firms. When a group of analysts gang up on a stock, they will do everything in their power to push or pop a stock via upgrade, downgrade, coverage initiated, coverage resumed, reiterated/price target change and other strategies. As a rule, try not to make a decision base on these announcements.
The analyst equity ratings changes provided here are published daily during market hours. They are listed with ticker symbol, company name, analyst/brokerage name and rating change date. Click on view chart to view Moving average (MA), On-Balance volume (OBV), Accumulation/Distribution line, Aroon indicator, Exponential moving average (EMA), Percentage Price Oscillator (PPO), Parabolic SAR, Average directional index, Stochastic oscillator, Standard deviation, Bollinger bands, Fibonacci retracement, Williams Percent Range (%R), Ichimoku cloud, and other technical indicators.